Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers-Reference-Cited by-同舟云学术

Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers

Published:2011-02-24 Issue:3-4 Volume:5 Page:159-166
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Foucher Christelle,Schiffer Eric,Mischak Harald,Ansquer Jean-Claude,Wilbraham Darren

Funder

The Research Unit staff at Quintiles, London

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201000076/fullpdf

Reference36 articles.

1. Fenofibrate. A review of its use in primary dyslipidemia, the metabolic syndrome and type 2 diabetes;Keating;Drugs,2007

2. Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency [in French];Hottelart;Nephrologie,1999

3. Implication of fibrate therapy for homocysteine;Goffin;Lancet,1999

4. Fenofibrate-induced elevation in serum creatinine;Ritter;Pharmacotherapy,2001

5. Fenofibrate increases creatininemia by increasing metabolic production of creatinine;Hottelart;Nephron,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary peptidomics in kidney disease and drug research;Expert Opinion on Drug Discovery;2017-12-19

2. Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adults;Journal of Clinical Lipidology;2014-07

3. Historical perspective of peptidomics;EuPA Open Proteomics;2014-06

4. CE–MS for proteomics: Advances in interface development and application;Journal of Proteomics;2012-07

5. Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux;Pediatrics;2012-02-01